Science Explorer Back to mapMap
Discussion
Researcher · Singapore Immunology Network · Singapore

Subhra Kumar Biswas

Subhra Kumar Biswas publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Immune cells in cancer, Immune Response and Inflammation and Immune Cell Function and Interaction.

OpenAlex
World rank
#65,141
of 7,710,434 ranked researchers
Rank in Singapore
#439
of 23,642
Works
122
Citations
29k
Citations per work
238.3
h-index
49
i10-index 68Top 4.5% in Immunology
Subhra Kumar Biswas

What does Subhra Kumar Biswas research?

Subhra Kumar Biswas's work is mostly in Immunology and Microbiology (44%), Medicine (22%), Biochemistry, Genetics and Molecular Biology (15%).

Life Sciences: 73 works · 59.5% of their workImmunology and Microbiology: 54 works · 44.3% of their workImmunology: 54 works · 44.3% of their workBiochemistry, Genetics and Molecular Biology: 19 works · 15.2% of their workMolecular Biology: 12 works · 9.5% of their workCancer Research: 7 works · 5.7% of their workHealth Sciences: 26 works · 21.7% of their workMedicine: 26 works · 21.7% of their workOncology: 16 works · 13.2% of their workEpidemiology: 6 works · 5.1% of their workInfectious Diseases: 4 works · 3.4% of their workEverything else: 23 works · 18.8% of their workTHEIR WORKSubhra KumarBiswas122works
Life Sciences60%Health Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology5444.3%
    2. Biochemistry, Genetics and Molecular Biology1915.2%
    1. Medicine2621.7%
  3. Everything else2318.8%
  1. 1Immunology44% of their works
  2. 2Oncology13% of their works
  3. 3Molecular Biology10% of their works
  4. 4Cancer Research6% of their works
  5. 5Epidemiology5% of their works
  6. 6Infectious Diseases3% of their works

Research topics

Which keywords describe Subhra Kumar Biswas's research?

The keywords of their largest research topics: Inflammation, Cancer, Immunity, Activation, Macrophage, Macrophages, Pattern Recognition Receptors and Toll-like Receptors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Inflammation1066 topics
  2. Cancer572 topics
  3. Immunity572 topics
  4. Activation501 topic
  5. Macrophage501 topic
  6. Macrophages283 topics
  7. Pattern Recognition Receptors201 topic
  8. Toll-like Receptors201 topic
  9. NK Cell Recognition151 topic
  10. Natural Killer Cells151 topic
  11. Cancer Metastasis141 topic
  12. Chemokine Receptors141 topic
  13. CD47131 topic
  14. apoptotic cells131 topic
  15. Adipose Tissue81 topic
  16. Obesity81 topic
  17. Endocan71 topic
  18. NF-?B71 topic
  19. Signaling71 topic
  20. TREM-171 topic

Where does Subhra Kumar Biswas work?

Subhra Kumar Biswas's main affiliation in the publication record is Singapore Immunology Network, Singapore.

How many publications and citations does Subhra Kumar Biswas have?

OpenAlex counts 122 works and 29,078 citations for Subhra Kumar Biswas, an h-index of 49, ranking #65,141 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Subhra Kumar Biswas. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.